First human test for potential muscle disease drug
NCT ID NCT07317063
Summary
This early-stage study tested the safety and how the body processes a single dose of an experimental drug called GRT6019 in 18 healthy male volunteers. Researchers specifically checked if taking the drug with food versus on an empty stomach changed how it was absorbed. The goal was to gather basic safety data and understand how the drug behaves in the body before testing it in people with Duchenne muscular dystrophy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY (DMD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Biotrial, Inc
Newark, New Jersey, 07103, United States
Conditions
Explore the condition pages connected to this study.